Radiolabelled GLP-1 analogues forin vivotargeting of insulinomas

Value of the radiolabelled GLP-1 receptor antagonist exendin(9–39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans

(2011) Beatrice Waser et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

(2010) Maarten Brom et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging

(2009) Eri Mukai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides

(2009) R. Mansi et al.   CLINICAL CANCER RESEARCH

Design, Synthesis, and Biological Evaluation of an Antagonist−Bombesin Analogue as Targeting Vector

(2008) Wael R. Abd-Elgaliel et al.   BIOCONJUGATE CHEMISTRY

Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting

(2008) R. Cescato et al.   JOURNAL OF NUCLEAR MEDICINE

Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas

(2008) Damian Wild et al.   NEW ENGLAND JOURNAL OF MEDICINE